Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT02949427
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 4 to 21 years.
* Group 1: Patients with newly confirmed diagnosis of acute myeloid leukemia (AML).
* Group 2: Patients scheduled to receive conditioning for allogeneic HSCT within 7 days.
Exclusion Criteria:
* Patients in group 1 who have received chemotherapy for more than 72 hours prior to enrollment (group 1) or started preparative regimen for allogenic stem cell transplant (group 2).
* Patients who are unable to perform the oral rinse or nasal swab collection procedure.
* Patients who have any condition that would place them at unnecessary risk secondary to providing oral and nasal samples.
* Inability or unwillingness of research participant or legal guardian/representative to give written informed consent for study participation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
21 Years
Study:
NCT02949427
Study Brief:
Protocol Section:
NCT02949427